Canton Biologics
Guangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese CDMO providing full-service biologics manufacturing for drug developers.
OncologyImmunology
Technology Platform
An integrated biologics CDMO platform offering cell line development, process optimization, and GMP manufacturing for monoclonal antibodies and other recombinant proteins.
Opportunities
Explosive growth of the Chinese biopharma industry driving increased demand for high-quality outsourcing partners.
Risk Factors
High capital expenditure requirements for facility expansion and potential pricing pressure in a competitive CDMO market.
Competitive Landscape
Faces intense competition from larger, established CDMOs but benefits from strong regional demand and a specialized service focus.